EGFR and glioblastoma: Furthermore, IF staining of human GBM tissues revealed that LAIR1+ cells were predominantly CD45+, with no significant overlap with EGFR-expressing tumor cells (Supplemental Figure 1D), a marker in most GBMs (29, 30).